Skip to main content

Table 1 Patient characteristics

From: Characteristics of immunoglobulin G4-related aortitis/periaortitis and periarteritis on fluorodeoxyglucose positron emission tomography/computed tomography co-registered with contrast-enhanced computed tomography

No.

Age (y)

Sex

Diagnostic criteria

Positive histopathological site

Interval between CECT and FDG-PET/CT(d)

Serum IgG4 value (mg/dL)

Vascular involvement

Other positive site

1

79

F

Definite

Pancreas

38

N/A

+

LN, SG, P

2

75

M

Definite

Minor salivary gland

7

953

+

LN

3

61

M

Definite

Minor salivary gland, bile duct

7

968

+

LN

4

70

M

Definite

Gall bladder

9

802

+

LN, P

5

67

M

Definite

Nasal mucosa

1

1390

+

LN, SG, C

6

73

M

Definite

Bile duct

17

1370

+

LN, SG, C, P

7

74

M

Definite

Lung

21

384

+

LN, SG, C

8

61

F

Definite

Pancreas

12

149

+

LN, SG, P

9

71

M

Definite

−

43

N/A

+

LN, P

10

77

M

Definite

−

6

N/A

+

LN

11

69

M

Definite

−

6

733

+

LN, SG

12

71

M

Definite

−

8

469

+

LN, SG, P

13

68

F

Definite

−

13

571

+

LN, P

14

68

M

Definite

−

28

877

+

LN, SG, C, P

15

58

M

Definite

−

12

326

+

LN, SG, P

16

78

M

Definite

Abdominal aorta

3

225

−

P

17

77

M

Definite

Bile duct

8

89.8

−

LN, P

18

54

M

Definite

Nasal mucosa, bile duct

6

455

−

LN, SG, P

19

73

F

Definite

Lacrimal gland

28

N/A

−

LN

20

55

F

Definite

Minor salivary gland

80

N/A

−

SG

21

60

F

Definite

Nasal mucosa

26

N/A

−

LN, SG

22

78

M

Definite

Minor salivary gland, nasal mucosa

11

888

−

LN, SG

23

50

M

Definite

Nasal mucosa

5

408

−

LN, P

24

67

M

Definite

Nasal mucosa

13

377

−

a

25

51

F

Definite

Lacrimal gland

1

398

−

LN, SG

26

45

M

Definite

Submandibular gland

20

N/A

−

LN, C

27

83

M

Definite

Minor salivary gland

49

905

−

LN, SG

28

78

F

Definite

Pancreas

31

243

−

LN, P

29

39

F

Definite

Lymph node

3

479

−

LN, SG

30

75

M

Definite

−

88

N/A

−

b

31

73

F

Definite

−

56

N/A

−

LN, SG

32

66

M

Definite

−

32

N/A

−

C

33

59

F

Definite

−

8

N/A

−

LN, SG, C, P

34

67

M

Definite

−

33

526

−

C, P

35

60

M

Definite

−

23

862

−

LN, SG

36

46

F

Definite

−

30

797

−

LN, SG

37

58

F

Definite

−

60

977

−

LN, SG

  1. Y year, d days, M male, F female, + positive, − negative, N/A not available, LN lymph node, SG salivary gland, C chest (pleura/paravertebra), P pancreas
  2. a(Patient no. 24) A patient with small hypovascular lesions in the bilateral kidney on CECT; the FDG-PET/CT findings could not be assessed due to physiological uptake by the renal parenchyma. This patient was treated for IgG4-RD
  3. b(Patient no. 30) A patient with abnormal pancreas findings on CECT, without significant abnormal FDG uptake. The patient was diagnosed as having autoimmune pancreatitis using endoscopic retrograde cholangiopancreatography